Cells lacking DNA topoisomerase IIβ are resistant to genistein

Journal of Natural Products

Volumn 70, Issue 5, 2007, Pages 763-767

  López Lázaro, Miguel ^a,b   Willmore, Elaine ^a   Austin, Caroline A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) BETA; GENISTEIN; LUTEOLIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL ASSAY; CELL DEATH; CELL GROWTH; CLONOGENIC ASSAY; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOUSE; NONHUMAN;

ANIMALS; DNA; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; GENISTEIN; LUTEOLIN; MICE; MOLECULAR STRUCTURE;

MURINAE;

EID: 34250785684     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np060609z     Document Type: Article

References (36)

1. Champoux, J. J. Annu. Rev. Biochem. 2001, 70, 369-413.
2. Wang, J. C. Nat. Rev. Mol. Cell Biol. 2002, 3, 430-440.
3. Fortune, J. M.; Osheroff, N. Prog. Nucl. Acid Res. Mol. Biol. 2000, 64, 221-253.
4. Holden, J. A. Curr. Med. Chem. Anticancer Agents 2001, 1, 1-25.
5. Sordet, O.; Khan, Q. A.; Kohn, K. W.; Pommier, Y. Curr. Med. Chem. Anticancer Agents 2003, 3, 271-290.
6. Felix, C. A. Biochim. Biophys. Acta 1998, 1400, 233-255.
7. Felix, C. A. Med. Pediatr. Oncol. 2001, 36, 525-535.
8. Mistry, A. R.; Felix, C. A.; Whitmarsh, R. J.; Mason, A.; Reiter, A.; Cassinat, B.; Parry, A.; Walz, C.; Wiemels, J. L.; Segal, M. R.; Ades, L.; Blair, I. A.; Osheroff, N.; Peniket, A. J.; Lafage-Pochitaloff, M.; Cross, N. C.; Chomienne, C.; Solomon, E.; Fenaux, P.; Grimwade, D. N Engl. J. Med. 2005, 352, 1529-1538.
9. Hofland, K. F.; Thougaard, A. V.; Sehested, M.; Jensen, P. B. Clin. Cancer Res. 2005, 11, 3915-3924.
10. Lopez-Lazaro, M. Curr. Med. Chem. Anticancer Agents 2002, 2, 691-714.
11. Ren, W.; Qiao, Z.; Wang, H.; Zhu, L.; Zhang, L. Med. Res. Rev. 2003, 23, 519-534.
12. Manach, C.; Donovan, J. L. Free Radical Res. 2004, 38, 771-785.
13. Roginsky, A. B.; Ujiki, M. B.; Ding, X. Z.; Adrian, T. E. In Vivo 2005, 19, 61-67.
14. Strick, R.; Strissel, P. L.; Borgers, S.; Smith, S. L.; Rowley, J. D. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 4790-4795.
15. Galati, G.; O'Brien, P. J. Free Radical Biol. Med. 2004, 37, 287-303.
16. Rietjens, I. M.; Boersma, M. G.; van der, W. H.; Jeurissen, S. M.; Schutte, M. E.; Alink, G. M. Mutat. Res. 2005, 574, 124-138.
17. Cho, K. H.; Pezzuto, J. M.; Bolton, J. L.; Steele, V. E.; Kelloff, G. J.; Lee, S. K.; Constantinou, A. Eur. J. Cancer 2000, 36, 2146-2156.
18. Yamashita, Y.; Kawada, S.; Nakano, H. Biochem. Pharmacol. 1990, 39, 737-744.
19. Austin, C. A.; Patel, S.; Ono, K.; Nakane, H.; Fisher, L. M. Biochem. J. 1992, 282, 883-889.
20. Constantinou, A.; Mehta, R.; Runyan, C.; Rao, K.; Vaughan, A.; Moon, R. J. Nat. Prod. 1995, 58, 217-225.
21. Boege, F.; Straub, T.; Kehr, A.; Boesenberg, C.; Christiansen, K.; Andersen, A.; Jakob, F.; Kohrle, J. J. Biol. Chem. 1996, 271, 2262-2270.
22. Chowdhury, A. R.; Sharma, S.; Mandal, S.; Goswami, A.; Mukhopadhyay, S.; Majumder, H. K. Biochem. J. 2002, 366, 653-661.
23. Mittra, B.; Saha, A.; Chowdhury, A. R.; Pal, C.; Mandal, S.; Mukhopadhyay, S.; Bandyopadhyay, S.; Majumder, H. K. Mol. Med. 2000, 6, 527-541.
24. Lopez-Lazaro, M.; Martin-Cordero, C.; Tore, M. V.; Ayuso, M. J. J. Enzyme Inhib. Med. Chem. 2002, 17, 25-29.
25. Willmore, E.; Frank, A. J.; Padget, K.; Tilby, M. J.; Austin, C. A. Mol. Pharmacol. 1998, 54, 78-85.
26. Padget, K.; Carr, R.; Pearson, A. D.; Tilby, M. J.; Austin, C. A. Biochem. Pharmacol. 2000, 59, 629-638.
27. Errington, F.; Willmore, E.; Tilby, M. J.; Li, L.; Li, G.; Li, W.; Baguley, B. C.; Austin, C. A. Mol. Pharmacol. 1999, 56, 1309-1316.
28. Markovits, J.; Junqua, S.; Goldwasser, F.; Venuat, A. M.; Luccioni, C.; Beaumatin, J.; Saucier, J. M.; Bernheim, A.; Jacquemin-Sablon, A. Biochem. Pharmacol. 1995, 50, 177-186.
29. Turley, H.; Comley, M.; Houlbrook, S.; Nozaki, N.; Kikuchi, A.; Hickson, I. D.; Gatter, K.; Harris, A. L. Br. J. Cancer 1997, 75, 1340-1346.
30. Gatto, B.; Leo, E. Curr. Med. Chem. Anticancer Agents 2003, 3, 173-185.
31. Giaccone, G.; Ark-Otte, J.; Scagliotti, G.; Capranico, G.; van d., V.; Rubio, G.; Dalesio, O.; Lopez, R.; Zunino, F.; Walboomers, J. Biochim. Biophys. Acta 1995, 1264, 337-346.
32. Green, N. S.; Foss, T. R.; Kelly, J. W. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 14545-14550.
33. Lynch, A.; Harvey, J.; Aylott, M.; Nicholas, E.; Burman, M.; Siddiqui, A.; Walker, S.; Rees, R. Mutagenesis 2003, 18, 345-353.
34. McCarty, M. C. Med. Hypotheses 2006, 66, 1093-1114.
35. Borras, C.; Gambini, J.; Gomez-Cabrera, M. C.; Sastre, J.; Pallardo, F. V.; Mann, G. E.; Vina, J. FASEB J. 2006, 20, 2136-2138.
36. Cowell, I. G.; Willmore, E.; Chalton, D.; Marsh, K. L.; Jazrawi, E.; Fisher, L. M.; Austin, C. A. Exp. Cell Res. 1998, 243, 232-240.